Corcept Therapeutics Incorporated
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
5/10
|
34.49 | 61.47 | -43.9% | 25.18 | +36.99% |
| P/S |
|
7.59 | 33.58 | -77.4% |
|
|
| P/BV |
|
7.22 | 4.79 | 50.75% |
|
|
| P/FCF |
|
24.98 | 42.53 | -41.27% |
|
|
| Ev/Ebitda |
|
32.15 | -17.26 | -286.28% |
|
|
| Ev/S |
|
7.31 | 22.49 | -67.5% |
|
|
| Ev/FCF |
|
27.78 | 67.63 | -58.92% |
|
|
| E/P |
|
0.0335 | 0.0182 | 84.07% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
22.73 | -14.2 | -260.03% | 28.84 | -21.18% |
| ROE |
|
20.95 | 9.78 | 114.12% |
|
|
| ROA |
|
17.08 | 0.33 | 5074.26% |
|
|
| ROIC |
|
24.16 | 7.63 | 216.46% |
|
|
| ROS |
|
22 | -26.41 | -183.29% |
|
|
| ROCE |
|
21.43 | 14.76 | 45.21% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0014 | -3.68 | -100.04% | 0.0037 | -62.29% |
| Nеt Debt/Ebitda |
|
-1.23 | -4.07 | -69.63% |
|
|
| Debt/Ratio |
|
0.000243 | 0.199 | -99.88% |
|
|
| Debt/Equity |
|
0.000303 | 1.67 | -99.98% |
|
|
| Debt/Net Income |
|
0.0014 | 10.34 | -99.99% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.235 | -100% |
|
|
| Average dividend growth |
|
0 | 1.41 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.486 | -100% |
|
|
| Average percentage for payments |
|
15.97 | 43.64 | -63.41% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
7/10
|
57.38 | 76.2 | -24.7% | ||
| Growth impulse Ebitda in 5 years |
|
-2.94 | 44.75 | -106.57% | ||
| Growth impulse Net Income in 5 years |
|
12.68 | -15.36 | -182.55% | ||
| Growth impulse FCF in 5 years |
|
-6 | -31.68 | -81.06% | ||
| Growth impulse EPS in 5 years |
|
23.62 | -61.82 | -138.21% |
IP Score
4.95/10
